Diagnostic Accuracy of Morning Salivary Cortisol in the Assessment of the Hypothalamic-Pituitary-Adrenal Axis Recovery after Prolonged Corticosteroid Therapy in Children
Hormone Research in Paediatrics · 2024
DOI: 10.1159/000530939 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hormone Research in Paediatrics, 2024. Verfasst von María Gabriela Ballerini und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centro de Investigaciones Endocrinológicas "Dr. César Bergadá" (CEDIE) CONICET - FEI - División de Endocrinología, Hospital de Niños Ricardo Gutiérre…. Hauptthemen laut MEDLINE: Hydrocortisone, Glucocorticoids. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Introduction
Assessment of the hypothalamic-pituitary-adrenal (HPA) axis is necessary after prolonged glucocorticoid therapy withdrawal. Salivary cortisol reflects 65% of the free circulating cortisol fraction. Saliva collection is non-invasive and child friendly.
Objective
We aimed to evaluate the diagnostic accuracy of morning salivary cortisol (mSAF) to determine HPA recovery after prolonged corticosteroid therapy in children.
Methods
We conducted a prospective, validation study in 171 paediatric patients (mean ± SD age: 13.0 ± 4.4 years) who received glucocorticoids for >4 weeks (median and interquartile range: 11 [7–14] months) and were referred for therapy withdrawal. Serum and saliva samples were collected between 8 and 9 a.m. on the same day. Cortisol was measured by an electrochemiluminescence immunoassay (ECLIA) 48 h after cessation of glucocorticoid therapy. Serum cortisol ≥193 nmol/L was used as the reference cut-off value for HPA recovery after glucocorticoid withdrawal and mSAF as the index test.
Results
The cut-off concentration obtained by ROC for mSAF was ≥5.0 nmol/L. True positive and true negative results were observed in 85/171 and 40/171 children, respectively. The false-positive rate was low (3/171, 1.7%); however, false-negative results were observed in 43/171 (25%) children. The main ROC results (95% CI) were area under curve: 0.98 (0.96–0.99), sensitivity: 0.66 (0.57–0.75), specificity: 0.93 (0.81–0.99), positive predictive value: 0.97 (0.90–0.99), negative predictive value: 0.48 (0.37–0.59), LR+: 9.5, and diagnostic accuracy: 73.1%.
Conclusion
The present study supports that mSAF ≥5.0 nmol/L by ECLIA is a non-invasive biomarker for the assessment of HPA recovery after prolonged glucocorticoid therapy in paediatric patients, with a positive predictive value of 97%. This proposed cut-off should be further validated using gold standard techniques for steroid quantification such as liquid chromatography-tandem mass spectrometry.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centro de Investigaciones Endocrinológicas "Dr. César Bergadá" (CEDIE) CONICET - FEI - División de Endocrinología, Hospital de Niños Ricardo Gutiérrez, Buenos Aires, Argentina.
Zitieren
APA
Ballerini, M. G., Freire, A. V., Rodríguez, M. E., Suco Valle, S., Castro, S., Arcari, A., Bergadá, I., & Ropelato, M. G. (2024). Diagnostic Accuracy of Morning Salivary Cortisol in the Assessment of the Hypothalamic-Pituitary-Adrenal Axis Recovery after Prolonged Corticosteroid Therapy in Children. Hormone Research in Paediatrics. https://doi.org/10.1159/000530939
Vancouver
Ballerini MG, Freire AV, Rodríguez ME, Suco Valle S, Castro S, Arcari A, et al. Diagnostic Accuracy of Morning Salivary Cortisol in the Assessment of the Hypothalamic-Pituitary-Adrenal Axis Recovery after Prolonged Corticosteroid Therapy in Children. Hormone Research in Paediatrics. 2024. doi:10.1159/000530939
BibTeX
@article{Ballerini2024,
author = {Ballerini, María Gabriela and Freire, Analía Verónica and Rodríguez, María Eugenia and Suco Valle, Sofía and Castro, Sebastián and Arcari, Andrea and Bergadá, Ignacio and Ropelato, María Gabriela},
title = {Diagnostic Accuracy of Morning Salivary Cortisol in the Assessment of the Hypothalamic-Pituitary-Adrenal Axis Recovery after Prolonged Corticosteroid Therapy in Children},
journal = {Hormone Research in Paediatrics},
year = {2024},
doi = {10.1159/000530939}
}
EUVIMED